When considering the use of Semaglutide GLP-1 to manage glucose levels, it is important to understand how to tell if it is working properly
both these factors may improve brain health and explain the reduced risk of conditions like Alzheimers disease and dementia. While GLP-1RA drugs display effectiveness against a wide array of health problems, the magnitude of associated benefits is modest about a 10 percent to 20 percent reduction for most outcomes
The prescribing information accounts for the fact that levels are already sustained
Given the natural fluctuations in hormone levels and the intricate rhythms of human physiology throughout the day and over a persons lifetime, there is concern about the uncertain health ramifications of sustained elevation of incretin activity over decades of treatment
Shiiya, T
In addition, the Baltimore Longitudinal Study of Aging, a long-term follow-up study of an adult caucasian population, showed that IGT, and not impaired fasting glucose tolerance, elevates the risk of coronary heart disease [8]